{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:55:53Z","timestamp":1790841353087,"version":"4.1.0"},"reference-count":277,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03563-8","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:27:20Z","timestamp":1790792840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2984-2503","authenticated-orcid":false,"given":"Abhishek","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9747-0485","authenticated-orcid":false,"given":"Sourin","family":"Bhukta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-9432","authenticated-orcid":false,"given":"Deepak","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2041-1849","authenticated-orcid":false,"given":"Narahari N.","family":"Palei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-7335","authenticated-orcid":false,"given":"Amita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-0574","authenticated-orcid":false,"given":"Lucy","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"3563_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","volume":"7","author":"E Nance","year":"2022","unstructured":"Nance E, Pun SH, Saigal R, Sellers DL. Drug delivery to the central nervous system. Nat Rev Mater. 2022;7:314\u201331.","journal-title":"Nat Rev Mater"},{"key":"3563_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102642","volume":"64","author":"NA Emad","year":"2021","unstructured":"Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-Kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. J Drug Deliv Sci Technol. 2021;64:102642.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","volume":"529","author":"EM Abdou","year":"2017","unstructured":"Abdou EM, Kandil SM, El Miniawy HMF. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Int J Pharm. 2017;529:667\u201377.","journal-title":"Int J Pharm"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","volume":"36","author":"M Zheng","year":"2018","unstructured":"Zheng M, Tao W, Zou Y, Farokhzad OC, Shi B. Nanotechnology-based strategies for siRNA brain delivery for disease therapy. Trends Biotechnol. 2018;36:562\u201375.","journal-title":"Trends Biotechnol"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877\u201397.","journal-title":"Lancet Neurol"},{"key":"3563_CR6","doi-asserted-by":"crossref","unstructured":"Chan VKY, Leung MYM, Chan SSM, Yang D, Knapp M, Luo H, et al. Projecting the 10-year costs of care and mortality burden of depression until 2032: a Markov modelling study developed from real-world data. Lancet Reg Health\u2013West Paci. 2024;45.","DOI":"10.1016\/j.lanwpc.2024.101026"},{"key":"3563_CR7","doi-asserted-by":"crossref","unstructured":"Collaborators GBD 2017 USND, Feigin VL, Vos T, Alahdab F, Amit AML, B\u00e4rnighausen TW, et al. Burden of neurological disorders across the US from 1990-2017: a global burden of disease study. JAMA Neurol. 2021;78:165\u201376.","DOI":"10.1001\/jamaneurol.2020.4152"},{"key":"3563_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000506396","volume":"54","author":"RV Krishnamurthi","year":"2020","unstructured":"Krishnamurthi RV, Ikeda T, Feigin VL. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology. 2020;54:171\u20139.","journal-title":"Neuroepidemiology"},{"key":"3563_CR9","unstructured":"Denny A. Predicting the course of mild cognitive impairment in a memory disorder clinic sample. 2020."},{"key":"3563_CR10","doi-asserted-by":"publisher","first-page":"e1129","DOI":"10.1016\/S2214-109X(21)00164-9","volume":"9","author":"G Singh","year":"2021","unstructured":"Singh G, Sharma M, Kumar GA, Rao NG, Prasad K, Mathur P, et al. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990\u20132019. Lancet Glob Health. 2021;9:e1129\u201344.","journal-title":"Lancet Glob Health"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, et al. The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health. 2024;12:e1534\u201343.","journal-title":"Lancet Glob Health"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2010","unstructured":"Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2010;21:718\u201379.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3233\/JAD-215190","volume":"83","author":"K Morris","year":"2021","unstructured":"Morris K, Nami M, Bolanos JF, Lobo MA, Sadri-Naini M, Fiallos J, et al. Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) health initiative: A global consortium addressing the human and economic burden of brain, spine, and mental disorders through neurotech innovations and policies. J Alzheimer\u2019s Dis. 2021;83:1563\u2013601.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/pharmaceutics15122658","volume":"15","author":"S Bhunia","year":"2023","unstructured":"Bhunia S, Kolishetti N, Vashist A, Yndart Arias A, Brooks D, Nair M. Drug delivery to the brain: recent advances and unmet challenges. Pharmaceutics. 2023;15:2658.","journal-title":"Pharmaceutics"},{"key":"3563_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115196","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang C, Huang Y, Ma Y, Song Q, Chen H, et al. Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway. Adv Drug Deliv Rev. 2024. https:\/\/doi.org\/10.1016\/j.addr.2024.115196.","journal-title":"Adv Drug Deliv Rev"},{"key":"3563_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104756","author":"M Raghav","year":"2023","unstructured":"Raghav M, Gupta V, Awasthi R, Singh A, Kulkarni GT. Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104756.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/app9112219","volume":"9","author":"BA Aderibigbe","year":"2019","unstructured":"Aderibigbe BA, Naki T. Chitosan-based nanocarriers for nose to brain delivery. Appl Sci (Basel). 2019;9:2219.","journal-title":"Appl Sci (Basel)"},{"key":"3563_CR18","volume":"5","author":"G Kaur","year":"2023","unstructured":"Kaur G, Goyal J, Behera PK, Devi S, Singh SK, Garg V, et al. Unraveling the role of chitosan for nasal drug delivery systems: a review. Carbohydr Polym Technol Appl. 2023;5:100316.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3563_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105842","author":"A Salama","year":"2024","unstructured":"Salama A, Soliman GM, Elsherbiny N, Safwat MA. Chitosan-coated nanoemulsion for the direct nose-to-brain delivery of sildenafil: development and in vivo evaluation in a brain oxidative stress and inflammation model. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105842.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1567201815666181011121750","volume":"16","author":"M Qureshi","year":"2019","unstructured":"Qureshi M, Aqil M, Imam SS, Ahad A, Sultana Y. Formulation and evaluation of neuroactive drug loaded chitosan nanoparticle for nose to brain delivery: in-vitro characterization and in-vivo behavior study. Curr Drug Deliv. 2019;16:123\u201335.","journal-title":"Curr Drug Deliv"},{"key":"3563_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2019.02.012","volume":"560","author":"S Yu","year":"2019","unstructured":"Yu S, Xu X, Feng J, Liu M, Hu K. Chitosan and chitosan coating nanoparticles for the treatment of brain disease. Int J Pharm. 2019;560:282\u201393.","journal-title":"Int J Pharm"},{"key":"3563_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135356","author":"YA Hamdan","year":"2024","unstructured":"Hamdan YA, El-Mansoury B, Elouali S, Rachmoune K, Belbachir A, Oudadesse H, et al. A review of chitosan polysaccharides: neuropharmacological implications and tissue regeneration. Int J Biol Macromol. 2024. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135356.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.procbio.2019.06.014","volume":"84","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Liu G, Yang Y, Shao K, Wang Y, Liu W, et al. N-Acetyl chitooligosaccharides attenuate amyloid \u03b2-induced damage in animal and cell models of Alzheimer\u2019s disease. Process Biochem. 2019;84:161\u201371.","journal-title":"Process Biochem"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/md15110322","volume":"15","author":"Q-Q Ouyang","year":"2017","unstructured":"Ouyang Q-Q, Zhao S, Li S-D, Song C. Application of chitosan, chitooligosaccharide, and their derivatives in the treatment of Alzheimer\u2019s disease. Mar Drugs. 2017;15:322.","journal-title":"Mar Drugs"},{"key":"3563_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1061186X.2018.1512112","volume":"27","author":"S Naskar","year":"2019","unstructured":"Naskar S, Kuotsu K, Sharma S. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research. J Drug Target. 2019;27:379\u201393.","journal-title":"J Drug Target"},{"key":"3563_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28041963","volume":"28","author":"K Jafernik","year":"2023","unstructured":"Jafernik K, \u0141adniak A, Blicharska E, Czarnek K, Ekiert H, Wi\u0105cek AE, et al. Chitosan-based nanoparticles as effective drug delivery systems\u2014a review. Molecules. 2023;28:1963.","journal-title":"Molecules"},{"key":"3563_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050608","volume":"13","author":"C Bartos","year":"2021","unstructured":"Bartos C, Varga P, Szab\u00f3-R\u00e9v\u00e9sz P, Ambrus R. Physico-chemical and in vitro characterization of chitosan-based microspheres intended for nasal administration. Pharmaceutics. 2021;13:608.","journal-title":"Pharmaceutics"},{"key":"3563_CR28","doi-asserted-by":"crossref","unstructured":"Iacob AT, Lupascu FG, Apotrosoaei M, Vasincu IM, Tauser RG, Lupascu D, et al. Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers. 2021;1\u201336.","DOI":"10.3390\/pharmaceutics13040587"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fphar.2019.00204","volume":"10","author":"T Peng","year":"2019","unstructured":"Peng T, Jiang Y, Farhan M, Lazarovici P, Chen L, Zheng W. Anti-inflammatory effects of traditional Chinese medicines on preclinical in vivo models of brain ischemia-reperfusion-injury: prospects for neuroprotective drug discovery and therapy. Front Pharmacol. 2019;10:204.","journal-title":"Front Pharmacol"},{"key":"3563_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118999","volume":"278","author":"MN Kantak","year":"2022","unstructured":"Kantak MN, Bharate SS. Analysis of clinical trials on biomaterial and therapeutic applications of chitosan: a review. Carbohydr Polym. 2022;278:118999.","journal-title":"Carbohydr Polym"},{"key":"3563_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017;9:53.","journal-title":"Pharmaceutics"},{"key":"3563_CR32","first-page":"35","volume":"25","author":"MEI Badawy","year":"2025","unstructured":"Badawy MEI, Radwan MA. Chitin and chitosan biopolymers: I. A review of historical milestones, sourcing, chemistry, and production processes. J Pest Control Environ Sci. 2025;25:35\u201344.","journal-title":"J Pest Control Environ Sci"},{"key":"3563_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/nano11113019","volume":"11","author":"M Ko\u0142odziejska","year":"2021","unstructured":"Ko\u0142odziejska M, Jankowska K, Klak M, Wszo\u0142a M. Chitosan as an underrated polymer in modern tissue engineering. Nanomaterials (Basel). 2021;11:3019.","journal-title":"Nanomaterials (Basel)"},{"key":"3563_CR34","doi-asserted-by":"crossref","unstructured":"Aranaz I, Alc R, Concepci M. Chitosan\u202f: An overview of its properties and applications. 2021.","DOI":"10.3390\/polym13193256"},{"key":"3563_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/polym13193256","volume":"13","author":"I Aranaz","year":"2021","unstructured":"Aranaz I, Alc\u00e1ntara AR, Civera MC, Arias C, Elorza B, Heras Caballero A, et al. Chitosan: an overview of its properties and applications. Polymers (Basel). 2021;13:3256.","journal-title":"Polymers (Basel)"},{"key":"3563_CR36","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1007\/s12649-020-01244-6","volume":"12","author":"S Peter","year":"2021","unstructured":"Peter S, Lyczko N, Gopakumar D, Maria HJ, Nzihou A, Thomas S. Chitin and chitosan based composites for energy and environmental applications: a review. Waste Biomass Valorization. 2021;12:4777\u2013804.","journal-title":"Waste Biomass Valorization"},{"key":"3563_CR37","first-page":"478","volume":"16","author":"A Singh","year":"2024","unstructured":"Singh A. Exploring marine-derived bioactives for innovative cosmeceutical applications: A review. J Appl Nat Sci. 2024;16:478\u201394.","journal-title":"J Appl Nat Sci"},{"key":"3563_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/10601325.2019.1581576","volume":"56","author":"S Pokhrel","year":"2019","unstructured":"Pokhrel S, Yadav PN. Functionalization of chitosan polymer and their applications. J Macromol Sci A. 2019;56:450\u201375.","journal-title":"J Macromol Sci A"},{"key":"3563_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.als.2016.04.001","volume":"10","author":"S Ahmed","year":"2016","unstructured":"Ahmed S, Ikram S. Chitosan based scaffolds and their applications in wound healing. Achievements Life Sci. 2016;10:27\u201337.","journal-title":"Achievements Life Sci"},{"key":"3563_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-031-23112-4_11","volume-title":"Nasal drug delivery: formulations, developments, challenges, and solutions","author":"L Djekic","year":"2023","unstructured":"Djekic L. Novel mucoadhesive polymers for nasal drug delivery. In: Nasal drug delivery: formulations, developments, challenges, and solutions. 2023. p. 189\u2013234."},{"key":"3563_CR42","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/md8072117","volume":"8","author":"R Pangestuti","year":"2010","unstructured":"Pangestuti R, Kim S-K. Neuroprotective properties of chitosan and its derivatives. Mar Drugs. 2010;8:2117\u201328.","journal-title":"Mar Drugs"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bmcl.2008.12.019","volume":"19","author":"S-H Lee","year":"2009","unstructured":"Lee S-H, Park J-S, Kim S-K, Ahn C-B, Je J-Y. Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by A\u03b225\u201335 in PC12 cells. Bioorg Med Chem Lett. 2009;19:860\u20132.","journal-title":"Bioorg Med Chem Lett"},{"key":"3563_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.carbpol.2015.08.055","volume":"135","author":"T Nidheesh","year":"2016","unstructured":"Nidheesh T, Salim C, Rajini PS, Suresh PV. Antioxidant and neuroprotective potential of chitooligomers in Caenorhabditis elegans exposed to Monocrotophos. Carbohydr Polym. 2016;135:138\u201344.","journal-title":"Carbohydr Polym"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neulet.2008.08.040","volume":"444","author":"S Zhou","year":"2008","unstructured":"Zhou S, Yang Y, Gu X, Ding F. Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity. Neurosci Lett. 2008;444:270\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2008.08.040.","journal-title":"Neurosci Lett"},{"key":"3563_CR46","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/md13031267","volume":"13","author":"C Hao","year":"2015","unstructured":"Hao C, Gao L, Zhang Y, Wang W, Yu G, Guan H, et al. Acetylated chitosan oligosaccharides act as antagonists against glutamate-induced PC12 cell death via Bcl-2\/Bax signal pathway. Mar Drugs. 2015;13:1267\u201389. https:\/\/doi.org\/10.3390\/md13031267.","journal-title":"Mar Drugs"},{"key":"3563_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neulet.2013.08.046","volume":"554","author":"X Dai","year":"2013","unstructured":"Dai X, Chang P, Zhu Q, Liu W, Sun Y. Neuroscience Letters Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric \u03b2-amyloid 1\u201342-induced neurotoxicity. Neurosci Lett. 2013;554:64\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2013.08.046.","journal-title":"Neurosci Lett"},{"key":"3563_CR48","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.carbpol.2016.06.053","volume":"151","author":"X Wang","year":"2016","unstructured":"Wang X, Miao J, Yan C, Ge R, Liang T, Liu E, et al. Chitosan attenuates dibutyltin-induced apoptosis in PC12 cells through inhibition of the mitochondria-dependent pathway. Carbohydr Polym. 2016;151:996\u20131005.","journal-title":"Carbohydr Polym"},{"key":"3563_CR49","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.bmcl.2010.03.105","volume":"20","author":"W Xu","year":"2010","unstructured":"Xu W, Huang H, Lin C, Jiang Z-F. Chitooligosaccharides protect rat cortical neurons against copper induced damage by attenuating intracellular level of reactive oxygen species. Bioorg Med Chem Lett. 2010;20:3084\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"3563_CR50","doi-asserted-by":"publisher","unstructured":"Hao C, Wang W, Wang S, Zhang L, Guo Y. An overview of the protective effects of chitosan and acetylated chitosan oligosaccharides against neuronal disorders. 2017. https:\/\/doi.org\/10.3390\/md15040089.","DOI":"10.3390\/md15040089"},{"key":"3563_CR51","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1177\/13872877251379420","volume":"108","author":"Z Naserramezani","year":"2025","unstructured":"Naserramezani Z, Palizvan MR, Ganji A, Ghazavi A, Mosayebi G. Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer\u2019s disease: amelioration of cognitive deficits and neuroinflammation. J Alzheimers Dis. 2025;108:790\u2013804.","journal-title":"J Alzheimers Dis"},{"key":"3563_CR52","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey IIWH. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99:1654\u201373.","journal-title":"J Pharm Sci"},{"key":"3563_CR53","doi-asserted-by":"publisher","first-page":"7697122","DOI":"10.1155\/jnt\/7697122","volume":"2025","author":"FV Borbolla-Jim\u00e9nez","year":"2025","unstructured":"Borbolla-Jim\u00e9nez FV, Guti\u00e9rrez-Ruiz SC, Hern\u00e1ndez-Parra H, Pe\u00f1a-Corona SI, Tamez AA, Rivas-Amores RD, et al. Nanoparticles navigating the intranasal route: innovative approaches in neurodegenerative diseases. J Nanotechnol. 2025;2025:7697122.","journal-title":"J Nanotechnol"},{"key":"3563_CR54","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00050.2017","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2018. https:\/\/doi.org\/10.1152\/physrev.00050.2017.","journal-title":"Physiol Rev"},{"key":"3563_CR55","doi-asserted-by":"publisher","first-page":"961","DOI":"10.4155\/tde.15.32","volume":"6","author":"WJ Geldenhuys","year":"2015","unstructured":"Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR. Molecular determinants of blood\u2013brain barrier permeation. Ther Deliv. 2015;6:961\u201371.","journal-title":"Ther Deliv"},{"key":"3563_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2500\/ajra.2015.29.4149","volume":"29","author":"MM Miyake","year":"2015","unstructured":"Miyake MM, Bleier BS. The blood-brain barrier and nasal drug delivery to the central nervous system. Am J Rhinol Allergy. 2015;29:124\u20137.","journal-title":"Am J Rhinol Allergy"},{"key":"3563_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","volume":"37","author":"S Ding","year":"2020","unstructured":"Ding S, Khan AI, Cai X, Song Y, Lyu Z, Du D, et al. Overcoming blood\u2013brain barrier transport: Advances in nanoparticle-based drug delivery strategies. Mater Today. 2020;37:112\u201325.","journal-title":"Mater Today"},{"key":"3563_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","volume":"260","author":"M Agrawal","year":"2017","unstructured":"Agrawal M, Tripathi DK, Saraf S, Saraf S, Antimisiaris SG, Mourtas S, et al. Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease. J Control Release. 2017;260:61\u201377.","journal-title":"J Control Release"},{"key":"3563_CR59","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","volume":"10","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10:957\u201372.","journal-title":"Expert Opin Drug Deliv"},{"key":"3563_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104952","volume":"144","author":"F Gosselet","year":"2021","unstructured":"Gosselet F, Loiola RA, Roig A, Rosell A, Culot M. Central nervous system delivery of molecules across the blood-brain barrier. Neurochem Int. 2021;144:104952.","journal-title":"Neurochem Int"},{"key":"3563_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","volume":"44","author":"M Segarra","year":"2021","unstructured":"Segarra M, Aburto MR, Acker-Palmer A. Blood\u2013brain barrier dynamics to maintain brain homeostasis. Trends Neurosci. 2021;44:393\u2013405.","journal-title":"Trends Neurosci"},{"key":"3563_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuropharm.2016.08.025","volume":"120","author":"I M\u00e4ger","year":"2017","unstructured":"M\u00e4ger I, Meyer AH, Li J, Lenter M, Hildebrandt T, Leparc G, et al. Targeting blood-brain-barrier transcytosis\u2013perspectives for drug delivery. Neuropharmacology. 2017;120:4\u20137.","journal-title":"Neuropharmacology"},{"key":"3563_CR63","doi-asserted-by":"crossref","unstructured":"Av\u015far PA, Akku\u015f M. Serum ZO-1 and occludin levels in bipolar disorder patients. Eur Arch Psychiatry Clini Neurosci. 2025;1\u20139.","DOI":"10.1007\/s00406-025-02097-7"},{"key":"3563_CR64","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","volume":"53","author":"E Candelario-Jalil","year":"2022","unstructured":"Candelario-Jalil E, Dijkhuizen RM, Magnus T. Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke. 2022;53:1473\u201386.","journal-title":"Stroke"},{"key":"3563_CR65","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","volume":"76","author":"R Villase\u00f1or","year":"2019","unstructured":"Villase\u00f1or R, Lampe J, Schwaninger M, Collin L. Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier. Cell Mol Life Sci. 2019;76:1081\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"3563_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.xphs.2023.10.034","volume":"113","author":"H Sunakawa","year":"2024","unstructured":"Sunakawa H, Mizoi K, Takahashi R, Takahashi S, Ogihara T. Impact of P-glycoprotein-mediated drug-endogenous substrate interactions on androgen and blood-brain barrier permeability. J Pharm Sci. 2024;113:228\u201334.","journal-title":"J Pharm Sci"},{"key":"3563_CR67","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","volume":"19","author":"WM Pardridge","year":"2015","unstructured":"Pardridge WM. Blood\u2013brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery. Expert Opin Ther Targets. 2015;19:1059\u201372.","journal-title":"Expert Opin Ther Targets"},{"key":"3563_CR68","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.conb.2018.12.014","volume":"57","author":"S Ayloo","year":"2019","unstructured":"Ayloo S, Gu C. Transcytosis at the blood\u2013brain barrier. Curr Opin Neurobiol. 2019;57:32\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"3563_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coche.2020.08.009","volume":"30","author":"AG Sorets","year":"2020","unstructured":"Sorets AG, Rosch JC, Duvall CL, Lippmann ES. Caveolae-mediated transport at the injured blood\u2013brain barrier as an underexplored pathway for central nervous system drug delivery. Curr Opin Chem Eng. 2020;30:86\u201395.","journal-title":"Curr Opin Chem Eng"},{"key":"3563_CR70","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/cns.12405","volume":"21","author":"W Liu","year":"2015","unstructured":"Liu W, Wang Z, Wang Y, Tong L, Li Y, Wei X, et al. Increasing the permeability of the blood\u2013brain barrier in three different models in vivo. CNS Neurosci Ther. 2015;21:568\u201374.","journal-title":"CNS Neurosci Ther"},{"key":"3563_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"3563_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.594672","volume":"11","author":"S Bernardo-Castro","year":"2020","unstructured":"Bernardo-Castro S, Sousa JA, Br\u00e1s A, Cec\u00edlia C, Rodrigues B, Almendra L, et al. Pathophysiology of blood\u2013brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol. 2020;11:594672.","journal-title":"Front Neurol"},{"key":"3563_CR73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13365-023-01190-8","volume":"30","author":"A Rani","year":"2024","unstructured":"Rani A, Erg\u00fcn S, Karnati S, Jha HC. Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis. J Neurovirol. 2024;30:22\u201338.","journal-title":"J Neurovirol"},{"key":"3563_CR74","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, et al. GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18:521\u201330.","journal-title":"Nat Neurosci"},{"key":"3563_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4155\/tde-2019-0006","volume":"10","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Ryu JS, Vig PJS. Current strategies for therapeutic drug delivery after traumatic CNS injury. Ther Deliv. 2019;10:251\u201363.","journal-title":"Ther Deliv"},{"key":"3563_CR76","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.copbio.2019.01.013","volume":"60","author":"BJ Umlauf","year":"2019","unstructured":"Umlauf BJ, Shusta EV. Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS. Curr Opin Biotechnol. 2019;60:146\u201352.","journal-title":"Curr Opin Biotechnol"},{"key":"3563_CR77","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/10717544.2022.2064564","volume":"29","author":"X Li","year":"2022","unstructured":"Li X, Li S, Ma C, Li T, Yang L. Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia. Drug Deliv. 2022;29:1282\u201398.","journal-title":"Drug Deliv"},{"key":"3563_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1341295","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen X, Yu S, Gong G, Shu H. Research progress in brain-targeted nasal drug delivery. Front Aging Neurosci. 2024;15:1341295.","journal-title":"Front Aging Neurosci"},{"key":"3563_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70213","volume":"6","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Huang S, Peng L, Yang L, Zhang G, Liu T, et al. The nasal\u2013brain drug delivery route: mechanisms and applications to central nervous system diseases. MedComm. 2025;6:e70213.","journal-title":"MedComm"},{"key":"3563_CR80","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S525759","author":"M Patel","year":"2025","unstructured":"Patel M, Minglani VV, Vaddadi H, Jha LL, Patel LD, Huanbutta K, et al. Advancements in nanotherapeutics for the treatment of depression via intranasal pathway: a review. Int J Nanomedicine. 2025. https:\/\/doi.org\/10.2147\/IJN.S525759.","journal-title":"Int J Nanomedicine"},{"key":"3563_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2017.05.001","volume":"258","author":"X-C Yu","year":"2017","unstructured":"Yu X-C, Yang J-J, Jin B-H, Xu H-L, Zhang H-Y, Xiao J, et al. A strategy for bypassing the blood-brain barrier: facial intradermal brain-targeted delivery via the trigeminal nerve. J Control Release. 2017;258:22\u201333.","journal-title":"J Control Release"},{"key":"3563_CR82","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neuroimage.2015.09.023","volume":"124","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, Sprenger C, May A. Physiological brainstem mechanisms of trigeminal nociception: an fMRI study at 3T. Neuroimage. 2016;124:518\u201325.","journal-title":"Neuroimage"},{"key":"3563_CR83","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jconrel.2022.09.047","volume":"351","author":"T Akita","year":"2022","unstructured":"Akita T, Oda Y, Kimura R, Nagai M, Tezuka A, Shimamura M, et al. Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative. J Control Release. 2022;351:573\u201380.","journal-title":"J Control Release"},{"key":"3563_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1214450","volume":"11","author":"Y Xinchen","year":"2023","unstructured":"Xinchen Y, Jing T, Jiaoqiong G. Lipid-based nanoparticles via nose-to-brain delivery: a mini review. Front Cell Dev Biol. 2023;11:1214450.","journal-title":"Front Cell Dev Biol"},{"key":"3563_CR85","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","volume":"565","author":"B Chatterjee","year":"2019","unstructured":"Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H. Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges. Int J Pharm. 2019;565:258\u201368.","journal-title":"Int J Pharm"},{"key":"3563_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139\u201377.","journal-title":"J Control Release"},{"key":"3563_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111904","volume":"13","author":"F Maigler","year":"2021","unstructured":"Maigler F, Ladel S, Flamm J, G\u00e4nger S, Kurpiers B, Kiderlen S, et al. Selective CNS targeting and distribution with a refined region-specific intranasal delivery technique via the olfactory mucosa. Pharmaceutics. 2021;13:1904.","journal-title":"Pharmaceutics"},{"key":"3563_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.103091","volume":"68","author":"H Jain","year":"2022","unstructured":"Jain H, Prabhakar B, Shende P. Modulation of olfactory area for effective transportation of actives in CNS disorders. J Drug Deliv Sci Technol. 2022;68:103091.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR89","doi-asserted-by":"publisher","first-page":"209","DOI":"10.24272\/j.issn.2095-8137.2024.240","volume":"46","author":"X-Q Mi","year":"2025","unstructured":"Mi X-Q, Liu B-C, Qu L, Yuan Y, Li H, Xu A-Y, et al. Intranasal iron administration induces iron deposition, immunoactivation, and cell-specific vulnerability in the olfactory bulb of C57BL\/6 mice. Zool Res. 2025;46:209.","journal-title":"Zool Res"},{"key":"3563_CR90","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"S-H Jeong","year":"2023","unstructured":"Jeong S-H, Jang J-H, Lee Y-B. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;53:119\u201352.","journal-title":"J Pharm Investig"},{"key":"3563_CR91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44\u201352.","journal-title":"Life Sci"},{"key":"3563_CR92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ar.23816","volume":"302","author":"C Crespo","year":"2019","unstructured":"Crespo C, Liberia T, Blasco\u2010Ib\u00e1\u00f1ez JM, N\u00e1cher J, Varea E. Cranial pair I: the olfactory nerve. Anat Rec. 2019;302:405\u201327.","journal-title":"Anat Rec"},{"key":"3563_CR93","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jep.2017.07.026","volume":"209","author":"Z Abolhasanzadeh","year":"2017","unstructured":"Abolhasanzadeh Z, Ashrafi H, Badr P, Azadi A. Traditional neurotherapeutics approach intended for direct nose to brain delivery. J Ethnopharmacol. 2017;209:116\u201323.","journal-title":"J Ethnopharmacol"},{"key":"3563_CR94","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/all.16064","volume":"79","author":"Z Huang","year":"2024","unstructured":"Huang Z, Liu J, Sun L, Ong HH, Ye J, Xu Y, et al. Updated epithelial barrier dysfunction in chronic rhinosinusitis: targeting pathophysiology and treatment response of tight junctions. Allergy. 2024;79:1146\u201365.","journal-title":"Allergy"},{"key":"3563_CR95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pharmaceutics17040397","volume":"17","author":"KC Baral","year":"2025","unstructured":"Baral KC, Choi KY. Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances. Pharmaceutics. 2025;17:397.","journal-title":"Pharmaceutics"},{"key":"3563_CR96","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1461-5347(00)00302-3","volume":"3","author":"PD Ward","year":"2000","unstructured":"Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm Sci Technol Today. 2000;3:346\u201358.","journal-title":"Pharm Sci Technol Today"},{"key":"3563_CR97","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s520768","author":"H Wu","year":"2025","unstructured":"Wu H, Li C, Yuan H, Zhao J, Li S. Brain delivery strategies for biomacromolecular drugs: intranasal administration. Int J Nanomedicine. 2025. https:\/\/doi.org\/10.2147\/ijn.s520768.","journal-title":"Int J Nanomedicine"},{"key":"3563_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1124\/jpet.114.216705","volume":"351","author":"JA Falcone","year":"2014","unstructured":"Falcone JA, Salameh TS, Yi X, Cordy BJ, Mortell WG, Kabanov AV, et al. Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin. J Pharmacol Exp Ther. 2014;351:54\u201360.","journal-title":"J Pharmacol Exp Ther"},{"key":"3563_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103569","volume":"74","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Jogi G, Shah N, Athalye MN, Bamaniya N, Vora LK, et al. Advanced particulate carrier-mediated technologies for nasal drug delivery. J Drug Deliv Sci Technol. 2022;74:103569.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR100","doi-asserted-by":"crossref","unstructured":"Jadhav S, Sahoo S, Mishra SK. A Review: nose to brain drug delivery for various CNS disorders. Techno-Societal 2018: Proceedings of the 2nd international conference on advanced technologies for societal applications-Volume 1, Springer; 2019. pp. 375\u201385.","DOI":"10.1007\/978-3-030-16848-3_35"},{"key":"3563_CR101","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/17425247.2025.2489553","volume":"22","author":"P Papakyriakopoulou","year":"2025","unstructured":"Papakyriakopoulou P, Valsami G. The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders. Expert Opin Drug Deliv. 2025;22:823\u201339.","journal-title":"Expert Opin Drug Deliv"},{"key":"3563_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-822522-6.00029-1","volume-title":"Direct nose-to-brain drug delivery","author":"D Khunt","year":"2021","unstructured":"Khunt D, Misra M. Chapter 1 - An overview of anatomical and physiological aspects of the nose and the brain. In: Pardeshi CV, Souto EB, editors. Direct nose-to-brain drug delivery. Academic Press; 2021. p. 3\u201314. https:\/\/doi.org\/10.1016\/B978-0-12-822522-6.00029-1."},{"key":"3563_CR103","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10611860903386938","volume":"18","author":"S Khan","year":"2010","unstructured":"Khan S, Patil K, Bobade N, Yeole P, Gaikwad R. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target. 2010;18:223\u201334.","journal-title":"J Drug Target"},{"key":"3563_CR104","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","volume":"7","author":"P Arora","year":"2002","unstructured":"Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discovery Today. 2002;7:967\u201375.","journal-title":"Drug Discovery Today"},{"key":"3563_CR105","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4155\/tde-2022-0018","volume":"13","author":"D Patel","year":"2022","unstructured":"Patel D, Thakkar H. Formulation considerations for improving intranasal delivery of CNS acting therapeutics. Ther Deliv. 2022;13:371\u201381.","journal-title":"Ther Deliv"},{"key":"3563_CR106","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","volume":"12","author":"S Bahadur","year":"2020","unstructured":"Bahadur S, Pardhi DM, Rautio J, Rosenholm JM, Pathak K. Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS disorders. Pharmaceutics. 2020;12:1230.","journal-title":"Pharmaceutics"},{"key":"3563_CR107","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","volume":"10","author":"S G\u00e4nger","year":"2018","unstructured":"G\u00e4nger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10:116.","journal-title":"Pharmaceutics"},{"key":"3563_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.06.028","volume":"325","author":"GL See","year":"2020","unstructured":"See GL, Arce F Jr, Dahlizar S, Okada A, Fadli MFBM, Hijikuro I, et al. Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations. J Control Release. 2020;325:1\u20139.","journal-title":"J Control Release"},{"key":"3563_CR109","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.carbpol.2017.01.044","volume":"163","author":"SB Yarragudi","year":"2017","unstructured":"Yarragudi SB, Richter R, Lee H, Walker GF, Clarkson AN, Kumar H, et al. Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs. Carbohydr Polym. 2017;163:216\u201326.","journal-title":"Carbohydr Polym"},{"key":"3563_CR110","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/jamp.2019.1549","volume":"33","author":"SB Yarragudi","year":"2020","unstructured":"Yarragudi SB, Kumar H, Jain R, Tawhai M, Rizwan S. Olfactory targeting of microparticles through inhalation and bi-directional airflow: effect of particle size and nasal anatomy. J Aerosol Med Pulm Drug Deliv. 2020;33:258\u201370.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"3563_CR111","doi-asserted-by":"crossref","unstructured":"Dong J, Shang Y, Inthavong K, Chan H-K, Tu J. Numerical comparison of nasal aerosol administration systems for efficient nose-to-brain drug delivery. Pharm Res. 2018;35:5.","DOI":"10.1007\/s11095-017-2280-6"},{"key":"3563_CR112","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/08958378.2015.1066904","volume":"27","author":"GJM Garcia","year":"2015","unstructured":"Garcia GJM, Schroeter JD, Kimbell JS. Olfactory deposition of inhaled nanoparticles in humans. Inhal Toxicol. 2015;27:394\u2013403.","journal-title":"Inhal Toxicol"},{"key":"3563_CR113","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.neuroscience.2006.01.041","volume":"139","author":"LT Loftus","year":"2006","unstructured":"Loftus LT, Li H-F, Gray AJ, Hirata-Fukae C, Stoica BA, Futami J, et al. In vivo protein transduction to the CNS. Neuroscience. 2006;139:1061\u20137.","journal-title":"Neuroscience"},{"key":"3563_CR114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","volume":"198","author":"N Washington","year":"2000","unstructured":"Washington N, Steele RJC, Jackson SJ, Bush D, Mason J, Gill DA, et al. Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm. 2000;198:139\u201346.","journal-title":"Int J Pharm"},{"key":"3563_CR115","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jps.2600760905","volume":"76","author":"T Ohwaki","year":"1987","unstructured":"Ohwaki T, Ando H, Kakimoto F, Uesugi K, Watanabe S, Miyake Y, et al. Effects of dose, pH, and osmolarity on nasal absorption of secretin in rats II: histological aspects of the nasal mucosa in relation to the absorption variation due to the effects of pH and osmolarity. J Pharm Sci. 1987;76:695\u20138.","journal-title":"J Pharm Sci"},{"key":"3563_CR116","doi-asserted-by":"publisher","first-page":"003685042413042","DOI":"10.1177\/00368504241304200","volume":"107","author":"VB Yenigun","year":"2024","unstructured":"Yenigun VB, Yenigun A, Sagiroglu AA, Kocyigit A, Ozturan O. Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity. Sci Prog. 2024;107:00368504241304200.","journal-title":"Sci Prog"},{"key":"3563_CR117","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","volume":"29","author":"CR Behl","year":"1998","unstructured":"Behl CR, Pimplaskar HK, Sileno AP, Demeireles J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev. 1998;29:89\u2013116.","journal-title":"Adv Drug Deliv Rev"},{"key":"3563_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2022.100581","volume":"21","author":"S Chung","year":"2023","unstructured":"Chung S, Peters JM, Detyniecki K, Tatum W, Rabinowicz AL, Carrazana E. The nose has it: opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters. Epilepsy Behav Rep. 2023;21:100581.","journal-title":"Epilepsy Behav Rep"},{"key":"3563_CR119","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/17425247.2025.2568093","volume":"23","author":"AA D\u2019Souza","year":"2026","unstructured":"D\u2019Souza AA, DiFrancesco V, Yang A, Bleier BS, Amiji MM. Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery. Expert Opin Drug Deliv. 2026;23:17\u201336.","journal-title":"Expert Opin Drug Deliv"},{"key":"3563_CR120","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/pharmaceutics16070849","volume":"16","author":"F Susa","year":"2024","unstructured":"Susa F, Arpicco S, Pirri CF, Limongi T. An overview on the physiopathology of the blood\u2013brain barrier and the lipid-based nanocarriers for central nervous system delivery. Pharmaceutics. 2024;16:849.","journal-title":"Pharmaceutics"},{"key":"3563_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204866","volume":"25","author":"E Manek","year":"2020","unstructured":"Manek E, Darvas F, Petroianu GA. Use of biodegradable, chitosan-based nanoparticles in the treatment of Alzheimer\u2019s disease. Molecules. 2020;25:4866.","journal-title":"Molecules"},{"key":"3563_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010034","volume":"10","author":"F Sonvico","year":"2018","unstructured":"Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Stanis\u00e7uaski Guterres S, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10:34.","journal-title":"Pharmaceutics"},{"key":"3563_CR123","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/pharmaceutics16060746","volume":"16","author":"H Omidian","year":"2024","unstructured":"Omidian H, Gill EJ, Dey Chowdhury S, Cubeddu LX. Chitosan nanoparticles for intranasal drug delivery. Pharmaceutics. 2024;16:746.","journal-title":"Pharmaceutics"},{"key":"3563_CR124","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5:e551\u201367.","journal-title":"Lancet Public Health"},{"key":"3563_CR125","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10787-018-0468-y","volume":"26","author":"KGS Nair","year":"2018","unstructured":"Nair KGS, Ramaiyan V, Sukumaran SK. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis. Inflammopharmacology. 2018;26:675\u201384.","journal-title":"Inflammopharmacology"},{"key":"3563_CR126","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14336\/AD.2020.0103","volume":"11","author":"AK Shetty","year":"2020","unstructured":"Shetty AK, Zanirati G. The interstitial system of the brain in health and disease. Aging Dis. 2020;11:200.","journal-title":"Aging Dis"},{"key":"3563_CR127","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","volume":"135","author":"J-F Ghersi-Egea","year":"2018","unstructured":"Ghersi-Egea J-F, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135:337\u201361.","journal-title":"Acta Neuropathol"},{"key":"3563_CR128","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jddst.2015.05.002","volume":"32","author":"G Rassu","year":"2016","unstructured":"Rassu G, Soddu E, Cossu M, Gavini E, Giunchedi P, Dalpiaz A. Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review. J Drug Deliv Sci Technol. 2016;32:77\u201387.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR129","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4155\/tde.14.41","volume":"5","author":"PG Djupesland","year":"2014","unstructured":"Djupesland PG, Messina JC, Mahmoud RA. The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. Ther Deliv. 2014;5:709\u201333.","journal-title":"Ther Deliv"},{"key":"3563_CR130","first-page":"79","volume-title":"Applied head and neck anatomy for the facial cosmetic surgeon","author":"CE Niekrash","year":"2020","unstructured":"Niekrash CE. Anatomy of the nose and paranasal sinuses. In: Applied head and neck anatomy for the facial cosmetic surgeon. Springer; 2020. p. 79\u201384."},{"key":"3563_CR131","unstructured":"Adryana Rocha C. Development of polysaccharide nanoparticles for the nasal administration of drugs for the treatment of neurodegenerative diseases. 2019."},{"key":"3563_CR132","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1201\/9780429163043-14","volume-title":"Nanoscale networking and communications handbook","author":"S Usman","year":"2019","unstructured":"Usman S, Fawzy KA, Beevi R, Usman A. Basis of pharmaceutical formulation. In: Nanoscale networking and communications handbook. CRC Press; 2019. p. 281\u2013319."},{"key":"3563_CR133","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review. Drug Deliv Transl Res. 2013;3:42\u201362.","journal-title":"Drug Deliv Transl Res"},{"key":"3563_CR134","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","volume":"29","author":"H Kublik","year":"1998","unstructured":"Kublik H, Vidgren MT. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev. 1998;29:157\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"3563_CR135","doi-asserted-by":"crossref","unstructured":"Sabir F, Ain QU, Rahdar A, Yang Z, Barani M, Bilal M, et al. Functionalized nanoparticles in drug delivery: strategies to enhance direct nose-to-brain drug delivery via integrated nerve pathways. Synth Appl Nanoparticles. 2022;455\u201385.","DOI":"10.1007\/978-981-16-6819-7_21"},{"key":"3563_CR136","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/gels10050295","volume":"10","author":"W Kruczkowska","year":"2024","unstructured":"Kruczkowska W, Ga\u0142\u0119ziewska J, Grabowska K, Liese G, Buczek P, K\u0142osi\u0144ski KK, et al. Biomedical trends in stimuli-responsive hydrogels with emphasis on chitosan-based formulations. Gels. 2024;10:295.","journal-title":"Gels"},{"key":"3563_CR137","first-page":"49003","volume":"49","author":"F Shahidi","year":"2005","unstructured":"Shahidi F, Abuzaytoun R. Chitin, chitosan, and co-products: chemistry, production, applications, and health effects. Adv Food Nutr Res. 2005;49:49003\u20138.","journal-title":"Adv Food Nutr Res"},{"key":"3563_CR138","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-805417-8.00004-4","volume-title":"Immunity and inflammation in health and disease","author":"N Ghosh","year":"2018","unstructured":"Ghosh N, Das A, Chaffee S, Roy S, Sen CK. Reactive oxygen species, oxidative damage and cell death. In: Immunity and inflammation in health and disease. Elsevier; 2018. p. 45\u201355."},{"key":"3563_CR139","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2165\/00023210-200317100-00004","volume":"17","author":"S Mandel","year":"2003","unstructured":"Mandel S, Gr\u00fcnblatt E, Riederer P, Gerlach M, Levites Y, Youdim MBH. Neuroprotective strategies in Parkinson\u2019s disease: an update on progress. CNS Drugs. 2003;17:729\u201362.","journal-title":"CNS Drugs"},{"key":"3563_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14051003","volume":"14","author":"H Abbas","year":"2022","unstructured":"Abbas H, El Sayed NS, Youssef NAHA, Gaafar PME, Mousa MR, Fayez AM, et al. Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceutics. 2022;14:1\u201326. https:\/\/doi.org\/10.3390\/pharmaceutics14051003.","journal-title":"Pharmaceutics"},{"key":"3563_CR141","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11010-009-0284-1","volume":"337","author":"F Khodagholi","year":"2010","unstructured":"Khodagholi F, Eftekharzadeh B, Maghsoudi N, Rezaei PF. Chitosan prevents oxidative stress-induced amyloid \u03b2 formation and cytotoxicity in NT2 neurons: involvement of transcription factors Nrf2 and NF-\u03baB. Mol Cell Biochem. 2010;337:39\u201351.","journal-title":"Mol Cell Biochem"},{"key":"3563_CR142","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med. 2006;38:333\u201347.","journal-title":"Exp Mol Med"},{"key":"3563_CR143","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archneur.64.2.185","volume":"64","author":"O Aktas","year":"2007","unstructured":"Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F. Neuronal damage in brain inflammation. Arch Neurol. 2007;64:185\u20139.","journal-title":"Arch Neurol"},{"key":"3563_CR144","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3940(02)00066-6","volume":"321","author":"M-S Kim","year":"2002","unstructured":"Kim M-S, Sung M-J, Seo S-B, Yoo S-J, Lim W-K, Kim H-M. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid \u03b2 peptide and interleukin-1\u03b2. Neurosci Lett. 2002;321:105\u20139.","journal-title":"Neurosci Lett"},{"key":"3563_CR145","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.exer.2014.12.001","volume":"130","author":"I-M Fang","year":"2015","unstructured":"Fang I-M, Yang C-M, Yang C-H. Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats. Exp Eye Res. 2015;130:38\u201350. https:\/\/doi.org\/10.1016\/j.exer.2014.12.001.","journal-title":"Exp Eye Res"},{"key":"3563_CR146","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11033-026-11577-5","volume":"53","author":"A Hanbashi","year":"2026","unstructured":"Hanbashi A, Safhi AY, Jali A, Alshahi H, Yousif OEA, Sabei FY, et al. Exploring apoptotic pathways: implications for cancer, inflammation, and neurodegeneration. Mol Biol Rep. 2026;53:415.","journal-title":"Mol Biol Rep"},{"key":"3563_CR147","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.3390\/molecules27217207","volume":"27","author":"HG Dailah","year":"2022","unstructured":"Dailah HG. Potential of therapeutic small molecules in apoptosis regulation in the treatment of neurodegenerative diseases: an updated review. Molecules. 2022;27:7207.","journal-title":"Molecules"},{"key":"3563_CR148","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0955-2863(01)00218-2","volume":"13","author":"H-N Koo","year":"2002","unstructured":"Koo H-N, Jeong H-J, Hong S-H, Choi J-H, An N-H, Kim H-M. High molecular weight water-soluble chitosan protects against apoptosis induced by serum starvation in human astrocytes. J Nutr Biochem. 2002;13:245\u20139.","journal-title":"J Nutr Biochem"},{"key":"3563_CR149","unstructured":"Zab\u0142ocka A, Janusz M. The two faces of reactive oxygen species. Adv Hyg Exp Med. 2008;62."},{"key":"3563_CR150","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/10738584241246530","volume":"31","author":"P Zong","year":"2025","unstructured":"Zong P, Legere N, Feng J, Yue L. TRP channels in excitotoxicity. Neuroscientist. 2025;31:80\u201397.","journal-title":"Neuroscientist"},{"key":"3563_CR151","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.3390\/ijms160510526","volume":"16","author":"X Dai","year":"2015","unstructured":"Dai X, Hou W, Sun Y, Gao Z, Zhu S, Jiang Z. Chitosan oligosaccharides inhibit\/disaggregate fibrils and attenuate amyloid \u03b2-mediated neurotoxicity. Int J Mol Sci. 2015;16:10526\u201336. https:\/\/doi.org\/10.3390\/ijms160510526.","journal-title":"Int J Mol Sci"},{"key":"3563_CR152","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40259-016-0168-3","volume":"30","author":"G Evin","year":"2016","unstructured":"Evin G. Future therapeutics in Alzheimer\u2019s disease: development status of BACE inhibitors. BioDrugs. 2016;30:173\u201394.","journal-title":"BioDrugs"},{"key":"3563_CR153","doi-asserted-by":"crossref","unstructured":"Lukiw WJ. Emerging amyloid beta (A b) peptide modulators for the treatment of Alzheimer\u2019s disease (AD). 2008;255\u201372.","DOI":"10.1517\/14728214.13.2.255"},{"key":"3563_CR154","doi-asserted-by":"crossref","unstructured":"Okamura N, Suemoto T, Shiomitsu T, Suzuki M, Shimadzu H, Akatsu H, et al. A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain. 2004;24:247\u201355.","DOI":"10.1385\/JMN:24:2:247"},{"key":"3563_CR155","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/00365510701864610","volume":"69","author":"H Hampel","year":"2009","unstructured":"Hampel H, Shen Y. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer\u2019s disease. Scand J Clin Lab Invest. 2009;69:8\u201312.","journal-title":"Scand J Clin Lab Invest"},{"key":"3563_CR156","doi-asserted-by":"publisher","unstructured":"Byun H, Kim Y, Park P, Lin X, Kim S. Chitooligosaccharides as a novel b -secretase inhibitor. 2005;0:1\u20135. https:\/\/doi.org\/10.1016\/j.carbpol.2005.05.003.","DOI":"10.1016\/j.carbpol.2005.05.003"},{"key":"3563_CR157","doi-asserted-by":"publisher","unstructured":"Je J, Kim S. Water-soluble chitosan derivatives as a BACE1 inhibitor. 2005;13:6551\u20135. https:\/\/doi.org\/10.1016\/j.bmc.2005.07.004.","DOI":"10.1016\/j.bmc.2005.07.004"},{"key":"3563_CR158","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/ageing\/afl027","volume":"35","author":"N Tabet","year":"2006","unstructured":"Tabet N. Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: anti-inflammatories in acetylcholine clothing! Age Ageing. 2006;35:336\u20138.","journal-title":"Age Ageing"},{"key":"3563_CR159","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry","year":"2003","unstructured":"Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003;306:821\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"3563_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122049","volume":"13","author":"D Lee","year":"2021","unstructured":"Lee D, Minko T. Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier. Pharmaceutics. 2021;13:2049.","journal-title":"Pharmaceutics"},{"key":"3563_CR161","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.carbpol.2009.07.004","volume":"78","author":"NY Yoon","year":"2009","unstructured":"Yoon NY, Ngo D-N, Kim S-K. Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives. Carbohydr Polym. 2009;78:869\u201372.","journal-title":"Carbohydr Polym"},{"key":"3563_CR162","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/micr.20686","volume":"29","author":"Y Gong","year":"2009","unstructured":"Gong Y, Gong L, Gu X, Ding F. Chitooligosaccharides promote peripheral nerve regeneration in a rabbit common peroneal nerve crush injury model. Microsurgery. 2009;29:650\u20136.","journal-title":"Microsurgery"},{"key":"3563_CR163","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","volume":"152","author":"G Rassu","year":"2017","unstructured":"Rassu G, Soddu E, Posadino AM, Pintus G, Sarmento B, Giunchedi P, et al. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer\u2019s therapy. Colloids Surf, B. 2017;152:296\u2013301.","journal-title":"Colloids Surf, B"},{"key":"3563_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125565","volume":"675","author":"A Prabakaran","year":"2025","unstructured":"Prabakaran A, Rakshit D, Patel I, Susanna KJ, Mishra A, Radhakrishnanand P, et al. Enhanced cognitive function in mice through intranasal delivery of sinapic acid via chitosan-coated solid lipid nanoparticles. Int J Pharm. 2025;675:125565.","journal-title":"Int J Pharm"},{"key":"3563_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102164","volume":"61","author":"M Yasir","year":"2021","unstructured":"Yasir M, Chauhan I, Zafar A, Verma M, Noorulla KM, Tura AJ, et al. Buspirone loaded solid lipid nanoparticles for amplification of nose to brain efficacy: formulation development, optimization by Box-Behnken design, in-vitro characterization and in-vivo biological evaluation. J Drug Deliv Sci Technol. 2021;61:102164.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125197","volume":"670","author":"HA Nematalla","year":"2025","unstructured":"Nematalla HA, Elharoun M, Bargash SN, Abd-Alhaseeb MM, Sharafeldin HA, Zewail M, et al. Novel nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson\u2019s symptoms management: in vitro and in vivo evaluation in a rotenone-induced rat model. Int J Pharm. 2025;670:125197.","journal-title":"Int J Pharm"},{"key":"3563_CR167","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2015.06.054","volume":"134","author":"O Gartziandia","year":"2015","unstructured":"Gartziandia O, Herran E, Pedraz JL, Carro E, Igartua M, Hernandez RM. Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf B. 2015;134:304\u201313.","journal-title":"Colloids Surf B"},{"key":"3563_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102939","volume":"67","author":"KM Noorulla","year":"2022","unstructured":"Noorulla KM, Yasir M, Muzaffar F, Ghoneim MM, Almurshedi AS, Tura AJ, et al. Intranasal delivery of chitosan decorated nanostructured lipid carriers of buspirone for brain targeting: formulation development, optimization and in-vivo preclinical evaluation. J Drug Deliv Sci Technol. 2022;67:102939.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103631","volume":"75","author":"M Yasir","year":"2022","unstructured":"Yasir M, Zafar A, Noorulla KM, Tura AJ, Sara UVS, Panjwani D, et al. Nose to brain delivery of donepezil through surface modified NLCs: formulation development, optimization, and brain targeting study. J Drug Deliv Sci Technol. 2022;75:103631.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR170","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","volume":"106","author":"P Wavikar","year":"2017","unstructured":"Wavikar P, Pai R, Vavia P. Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics. J Pharm Sci. 2017;106:3613\u201322.","journal-title":"J Pharm Sci"},{"key":"3563_CR171","doi-asserted-by":"crossref","unstructured":"Kumar N, Gupta G Das, Arora D. DoE directed optimization, development and characterization of resveratrol loaded Nlc system for the nose to brain delivery in the management of glioblastoma multiforme. 2021.","DOI":"10.21203\/rs.3.rs-572155\/v1"},{"key":"3563_CR172","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","volume":"27","author":"KS Ahmed","year":"2019","unstructured":"Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C. Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J Drug Target. 2019;27:742\u201361.","journal-title":"J Drug Target"},{"key":"3563_CR173","doi-asserted-by":"crossref","unstructured":"Vieira DB, Gamarra LF. Getting into the brain: liposome-based strategies for effective drug delivery across the blood\u2013brain barrier. Int J Nanomed 2016;5381\u2013414.","DOI":"10.2147\/IJN.S117210"},{"key":"3563_CR174","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.msec.2017.02.012","volume":"75","author":"M Rasoulianboroujeni","year":"2017","unstructured":"Rasoulianboroujeni M, Kupgan G, Moghadam F, Tahriri M, Boughdachi A, Khoshkenar P, et al. Development of a DNA-liposome complex for gene delivery applications. Mater Sci Eng C Mater Biol Appl. 2017;75:191\u20137.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"3563_CR175","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S147650","author":"L Salade","year":"2017","unstructured":"Salade L, Wauthoz N, Deleu M, Vermeersch M, De Vriese C, Amighi K, et al. Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia. Int J Nanomedicine. 2017. https:\/\/doi.org\/10.2147\/IJN.S147650.","journal-title":"Int J Nanomedicine"},{"key":"3563_CR176","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpb.2018.06.011","volume":"129","author":"L Salade","year":"2018","unstructured":"Salade L, Wauthoz N, Vermeersch M, Amighi K, Goole J. Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery. Eur J Pharm Biopharm. 2018;129:257\u201366.","journal-title":"Eur J Pharm Biopharm"},{"key":"3563_CR177","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2012.04.007","volume":"430","author":"F Qiang","year":"2012","unstructured":"Qiang F, Shin H-J, Lee B-J, Han H-K. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Int J Pharm. 2012;430:161\u20136.","journal-title":"Int J Pharm"},{"key":"3563_CR178","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/08982104.2011.621127","volume":"22","author":"H Chen","year":"2012","unstructured":"Chen H, Wu J, Sun M, Guo C, Yu A, Cao F, et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res. 2012;22:100\u20139.","journal-title":"J Liposome Res"},{"key":"3563_CR179","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1208\/s12248-024-00967-x","volume":"26","author":"D Lee","year":"2024","unstructured":"Lee D, Shen AM, Garbuzenko OB, Minko T. Liposomal formulations of anti-Alzheimer drugs and siRNA for nose-to-brain delivery: design, safety and efficacy in vitro. AAPS J. 2024;26:99.","journal-title":"AAPS J"},{"key":"3563_CR180","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejpb.2018.02.010","volume":"127","author":"V Trotta","year":"2018","unstructured":"Trotta V, Pavan B, Ferraro L, Beggiato S, Traini D, Des Reis LG, et al. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Eur J Pharm Biopharm. 2018;127:250\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"3563_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.732954","volume":"12","author":"LM Spindler","year":"2021","unstructured":"Spindler LM, Feuerhake A, Ladel S, G\u00fcnday C, Flamm J, G\u00fcnday-T\u00fcreli N, et al. Nano-in-micro-particles consisting of PLGA nanoparticles embedded in chitosan microparticles via spray-drying enhances their uptake in the olfactory mucosa. Front Pharmacol. 2021;12:732954.","journal-title":"Front Pharmacol"},{"key":"3563_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111829","volume":"141","author":"Y Gao","year":"2021","unstructured":"Gao Y, Almalki WH, Afzal O, Panda SK, Kazmi I, Alrobaian M, et al. Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer\u2019s disease. Biomed Pharmacother. 2021;141:111829.","journal-title":"Biomed Pharmacother"},{"key":"3563_CR183","doi-asserted-by":"crossref","unstructured":"Tuna RW, Achmad NA, Kurniawan I, Khairiyah, Asaf MB, Sapiun Z, et al. Development of thermosensitive mucoadhesive gel incorporated lipid microspheres of donepezil for enhanced nose-to-brain delivery. J Biomater Sci Polym Ed. 2025;1\u201328.","DOI":"10.1021\/acs.langmuir.4c03530"},{"key":"3563_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138336","volume":"286","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Karmakar V, Chatterjee K, Chatterjee A, Dwivedi M, Gorain B. Chitosan nanoparticle-mediated nose-to-brain delivery of naringenin: attenuating memory decline in experimental animals via behavioural assessment and modulation of biochemical parameters. Int J Biol Macromol. 2025;286:138336. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138336.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR185","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1080\/17425247.2023.2228685","volume":"20","author":"DMF Hanna","year":"2023","unstructured":"Hanna DMF, Youshia J, Fahmy SF, George MY. Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS\/STING and HMGB1\/RAGE\/TLR2\/MYD88 inflammatory axes. Expert Opin Drug Deliv. 2023;20:1859\u201373. https:\/\/doi.org\/10.1080\/17425247.2023.2228685.","journal-title":"Expert Opin Drug Deliv"},{"key":"3563_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030829","volume":"15","author":"D Georgieva","year":"2023","unstructured":"Georgieva D, Nikolova D, Vassileva E, Kostova B. Chitosan-based nanoparticles for targeted nasal galantamine delivery as a promising tool in Alzheimer\u2019s disease therapy. Pharmaceutics. 2023;15:829.","journal-title":"Pharmaceutics"},{"key":"3563_CR187","doi-asserted-by":"publisher","first-page":"127217","DOI":"10.1016\/j.ijbiomac.2023.127217","volume":"253","author":"SAAA Hard","year":"2023","unstructured":"Hard SAAA, Shivakumar HN, Redhwan MAM. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine. Int J Biol Macromol. 2023;253:127217. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127217.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR188","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","volume":"13","author":"B Gabold","year":"2023","unstructured":"Gabold B, Adams F, Brameyer S, Jung K, Ried CL, Merdan T, et al. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Deliv Transl Res. 2023;13:822\u201338.","journal-title":"Drug Deliv Transl Res"},{"key":"3563_CR189","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fbioe.2020.00389","volume":"8","author":"DD Ojeda-Hern\u00e1ndez","year":"2020","unstructured":"Ojeda-Hern\u00e1ndez DD, Canales-Aguirre AA, Matias-Guiu J, Gomez-Pinedo U, Mateos-D\u00edaz JC. Potential of chitosan and its derivatives for biomedical applications in the central nervous system. Front Bioeng Biotechnol. 2020;8:389. https:\/\/doi.org\/10.3389\/fbioe.2020.00389.","journal-title":"Front Bioeng Biotechnol"},{"key":"3563_CR190","volume":"2013","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S. Intranasal, siRNA delivery to the brain by TAT\/MGF tagged PEGylated chitosan nanoparticles. J Pharm. 2013;2013:812387.","journal-title":"J Pharm"},{"key":"3563_CR191","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/1570159X20666220706121412","volume":"21","author":"S Sharma","year":"2023","unstructured":"Sharma S, Dang S. Nanocarrier-based drug delivery to brain: interventions of surface modification. Curr Neuropharmacol. 2023;21:517\u201335.","journal-title":"Curr Neuropharmacol"},{"key":"3563_CR192","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10667857.2019.1674522","volume":"35","author":"CV Pardeshi","year":"2020","unstructured":"Pardeshi CV, Belgamwar VS. Improved brain pharmacokinetics following intranasal administration of N, N, N-trimethyl chitosan tailored mucoadhesive NLCs. Mater Technol. 2020;35:249\u201366.","journal-title":"Mater Technol"},{"key":"3563_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2016.07.001","author":"L Liu","year":"2016","unstructured":"Liu L, Gao Q, Lu X, Zhou H. In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration. Asian J Pharm Sci. 2016. https:\/\/doi.org\/10.1016\/j.ajps.2016.07.001.","journal-title":"Asian J Pharm Sci"},{"key":"3563_CR194","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.msec.2015.01.030","volume":"49","author":"G-C Dong","year":"2015","unstructured":"Dong G-C, Kuan C-Y, Subramaniam S, Zhao J-Y, Sivasubramaniam S, Chang H-Y, et al. A potent inhibition of oxidative stress induced gene expression in neural cells by sustained ferulic acid release from chitosan based hydrogel. Mater Sci Eng C Mater Biol Appl. 2015;49:691\u20139.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"3563_CR195","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1039\/C1CS15203C","volume":"41","author":"Y Li","year":"2012","unstructured":"Li Y, Rodrigues J, Tom\u00e1s H. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev. 2012;41:2193\u2013221.","journal-title":"Chem Soc Rev"},{"key":"3563_CR196","first-page":"766","volume":"31","author":"G Wang","year":"2017","unstructured":"Wang G, Wang X, Huang L. Feasibility of chitosan-alginate (Chi-Alg) hydrogel used as scaffold for neural tissue engineering: a pilot study in vitro. Biotechnol Biotechnol Equip. 2017;31:766\u201373.","journal-title":"Biotechnol Biotechnol Equip"},{"key":"3563_CR197","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.carbpol.2015.10.048","volume":"136","author":"G Rassu","year":"2016","unstructured":"Rassu G, Salis A, Porcu EP, Giunchedi P, Roldo M, Gavini E. Composite chitosan\/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases. Carbohyd Polym. 2016;136:1338\u201347.","journal-title":"Carbohyd Polym"},{"key":"3563_CR198","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.carpta.2023.100332","volume":"6","author":"G Nerli","year":"2023","unstructured":"Nerli G, Robla S, Bartalesi M, Luceri C, D\u2019Ambrosio M, Csaba N, et al. Chitosan coated niosomes for nose-to-brain delivery of clonazepam: Formulation, stability and permeability studies. Carbohydr Polym Technol Appl. 2023;6:100332. https:\/\/doi.org\/10.1016\/j.carpta.2023.100332.","journal-title":"Carbohydr Polym Technol Appl"},{"key":"3563_CR199","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/pharmaceutics15061660","volume":"15","author":"M Perku\u0161i\u0107","year":"2023","unstructured":"Perku\u0161i\u0107 M, Ni\u017ei\u0107 Nodilo L, Ugrina I, \u0160poljari\u0107 D, Jakobu\u0161i\u0107 Brala C, Pepi\u0107 I, et al. Chitosan-based thermogelling system for nose-to-brain donepezil delivery: optimising formulation properties and nasal deposition profile. Pharmaceutics. 2023;15:1660.","journal-title":"Pharmaceutics"},{"key":"3563_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102939","volume":"67","author":"KM Noorulla","year":"2022","unstructured":"Noorulla KM, Yasir M, Muzaffar F, Roshan S, Ghoneim MM, Almurshedi AS, et al. Journal of Drug Delivery Science and Technology Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting\u202f: Formulation development, optimization and In-Vivo preclinical evaluation. JDDST. 2022;67:102939. https:\/\/doi.org\/10.1016\/j.jddst.2021.102939.","journal-title":"JDDST"},{"key":"3563_CR201","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2022.06.031","volume":"213","author":"S Ourani-pourdashti","year":"2022","unstructured":"Ourani-pourdashti S, Mirzaei E, Heidari R, Ashrafi H, Azadi A. Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. Int J Biol Macromol. 2022;213:1115\u201326. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.06.031.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR202","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101206","volume":"15","author":"F De Gaetano","year":"2022","unstructured":"De Gaetano F, d\u2019Avanzo N, Mancuso A, De Gaetano A, Paladini G, Caridi F, et al. Chitosan\/cyclodextrin nanospheres for potential nose-to-brain targeting of idebenone. Pharmaceuticals. 2022;15:1206.","journal-title":"Pharmaceuticals"},{"key":"3563_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121244","volume":"610","author":"H Abbas","year":"2021","unstructured":"Abbas H, Refai H, El Sayed N, Rashed LA, Mousa MR, Zewail M. Superparamagnetic iron oxide loaded chitosan coated bilosomes for magnetic nose to brain targeting of resveratrol. Int J Pharm. 2021;610:121244. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121244.","journal-title":"Int J Pharm"},{"key":"3563_CR204","doi-asserted-by":"publisher","first-page":"102242","DOI":"10.1016\/j.jddst.2020.102242","volume":"61","author":"N Dhas","year":"2021","unstructured":"Dhas N, Mehta T. Intranasal delivery of chitosan decorated PLGA core \/shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer\u2019s disease. J Drug Deliv Sci Technol. 2021;61:102242. https:\/\/doi.org\/10.1016\/j.jddst.2020.102242.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR205","doi-asserted-by":"publisher","first-page":"102176","DOI":"10.1016\/j.jddst.2020.102176","volume":"61","author":"B Wilson","year":"2021","unstructured":"Wilson B, Mohamed Alobaid BN, Geetha KM, Jenita JL. Chitosan nanoparticles to enhance nasal absorption and brain targeting of sitagliptin to treat Alzheimer\u2019s disease. J Drug Deliv Sci Technol. 2021;61:102176. https:\/\/doi.org\/10.1016\/j.jddst.2020.102176.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3563_CR206","doi-asserted-by":"publisher","first-page":"104875","DOI":"10.1016\/j.neuint.2020.104875","volume":"141","author":"FNS Fachel","year":"2020","unstructured":"Fachel FNS, Michels LR, Azambuja JH, Lenz GS, Gelsleichter NE, Endres M, et al. Chitosan-coated rosmarinic acid nanoemulsion nasal administration protects against LPS-induced memory deficit, neuroinflammation, and oxidative stress in Wistar rats. Neurochem Int. 2020;141:104875. https:\/\/doi.org\/10.1016\/j.neuint.2020.104875.","journal-title":"Neurochem Int"},{"key":"3563_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/polym12112589","volume":"12","author":"N Shrestha","year":"2020","unstructured":"Shrestha N, Khan S, Neupane YR, Dang S, Md S, Fahmy UA, et al. Tailoring midazolam-loaded chitosan nanoparticulate formulation for enhanced brain delivery via intranasal route. Polymers (Basel). 2020;12:2589.","journal-title":"Polymers (Basel)"},{"key":"3563_CR208","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/brainsci9100275","volume":"9","author":"S Md","year":"2019","unstructured":"Md S, Alhakamy NA, Aldawsari HM, Asfour HZ. Neuroprotective and antioxidant effect of naringenin-loaded nanoparticles for nose-to-brain delivery. Brain Sci. 2019;9:275.","journal-title":"Brain Sci"},{"key":"3563_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11010008","author":"G Rassu","year":"2019","unstructured":"Rassu G, Porcu EP, Fancello S, Obinu A, Senes N, Galleri G, et al. Intranasal delivery of genistein-loaded nanoparticles as a potential preventive system against neurodegenerative disorders. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11010008.","journal-title":"Pharmaceutics"},{"key":"3563_CR210","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jconrel.2018.12.007","volume":"294","author":"F Rinaldi","year":"2019","unstructured":"Rinaldi F, Seguella L, Gigli S, Hanieh PN, Del Favero E, Cant\u00f9 L, et al. In Pentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice. J Control Release. 2019;294:17\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.007.","journal-title":"J Control Release"},{"key":"3563_CR211","doi-asserted-by":"crossref","unstructured":"Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, et al. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Int J Nanomed. 2018;705\u201318.","DOI":"10.2147\/IJN.S151474"},{"key":"3563_CR212","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","volume":"109","author":"R Raj","year":"2018","unstructured":"Raj R, Wairkar S, Sridhar V, Gaud R. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity. Int J Biol Macromol. 2018;109:27\u201335. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.12.056.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR213","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.ijbiomac.2018.09.032","volume":"120","author":"CV Pardeshi","year":"2018","unstructured":"Pardeshi CV, Belgamwar VS. N, N, N-trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery. Int J Biol Macromol. 2018;120:2560\u201371. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.09.032.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR214","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","volume":"199","author":"FNS Fachel","year":"2018","unstructured":"Fachel FNS, Medeiros-Neves B, Dal Pr\u00e1 M, Schuh RS, Veras KS, Bassani VL, et al. Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery\u2014In vitro studies. Carbohydr Polym. 2018;199:572\u201382. https:\/\/doi.org\/10.1016\/j.carbpol.2018.07.054.","journal-title":"Carbohydr Polym"},{"key":"3563_CR215","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2016.02.032","volume":"227","author":"M Van Woensel","year":"2016","unstructured":"Van Woensel M, Wauthoz N, Rosi\u00e8re R, Mathieu V, Kiss R, Lefranc F, et al. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration. J Control Release. 2016;227:71\u201381. https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.032.","journal-title":"J Control Release"},{"key":"3563_CR216","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijbiomac.2016.06.001","volume":"91","author":"N Ahmad","year":"2016","unstructured":"Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, et al. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia. Int J Biol Macromol. 2016;91:640\u201355. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.06.001.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR217","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijbiomac.2016.03.019","volume":"88","author":"N Ahmad","year":"2016","unstructured":"Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Int J Biol Macromole. 2016;88:320\u201332. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.03.019.","journal-title":"Int J Biol Macromole"},{"key":"3563_CR218","first-page":"865","volume":"44","author":"D Singh","year":"2016","unstructured":"Singh D, Rashid M, Hallan SS, Mehra NK, Prakash A, Mishra N. Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression. Artif Cells Nanomed Biotechnol. 2016;44:865\u201377.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3563_CR219","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pharmaceutics10020038","volume":"10","author":"F Rinaldi","year":"2018","unstructured":"Rinaldi F, Hanieh PN, Chan LKN, Angeloni L, Passeri D, Rossi M, et al. Chitosan glutamate-coated niosomes: A proposal for nose-to-brain delivery. Pharmaceutics. 2018;10:38.","journal-title":"Pharmaceutics"},{"key":"3563_CR220","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijbiomac.2016.04.076","volume":"89","author":"B Shah","year":"2016","unstructured":"Shah B, Khunt D, Misra M, Padh H. Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route*. Int J Biol Macromol. 2016;89:206\u201318. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.04.076.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR221","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","volume":"104","author":"YSR Elnaggar","year":"2015","unstructured":"Elnaggar YSR, Etman SM, Abdelmonsif DA, Abdallah OY. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer\u2019s disease: optimization, biological efficacy, and potential toxicity. J Pharm Sci. 2015;104:3544\u201356. https:\/\/doi.org\/10.1002\/jps.24557.","journal-title":"J Pharm Sci"},{"key":"3563_CR222","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijbiomac.2013.06.041","volume":"61","author":"M Kumar","year":"2013","unstructured":"Kumar M, Pandey RS, Patra KC, Jain SK, Soni ML, Dangi JS, et al. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery. Int J Biol Macromol. 2013;61:189\u201395. https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.06.041.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR223","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3797\/scipharm.1208-18","volume":"81","author":"N Gulati","year":"2013","unstructured":"Gulati N, Nagaich U, Saraf SA. Intranasal delivery of chitosan nanoparticles for migraine therapy. Sci Pharm. 2013;81:843.","journal-title":"Sci Pharm"},{"key":"3563_CR224","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","volume":"47","author":"M Fazil","year":"2012","unstructured":"Fazil M, Md S, Haque S, Kumar M, Baboota S, Kaur Sahni J, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47:6\u201315. https:\/\/doi.org\/10.1016\/j.ejps.2012.04.013.","journal-title":"Eur J Pharm Sci"},{"key":"3563_CR225","doi-asserted-by":"crossref","unstructured":"Alam S, Khan ZI, Mustafa G, Kumar M, Islam F, Bhatnagar A, et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Int J Nanomed. 2012;5705\u201318.","DOI":"10.2147\/IJN.S35329"},{"key":"3563_CR226","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s12276-025-01436-x","volume":"57","author":"Q Guo","year":"2025","unstructured":"Guo Q, Qian C, Wang X, Qian Z-M. Transferrin receptors. Exp Mol Med. 2025;57:724\u201332.","journal-title":"Exp Mol Med"},{"key":"3563_CR227","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/03639045.2020.1730396","volume":"46","author":"B Nabi","year":"2020","unstructured":"Nabi B, Rehman S, Fazil M, Khan S, Baboota S, Ali J. Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Dev Ind Pharm. 2020;46:471\u201383.","journal-title":"Drug Dev Ind Pharm"},{"key":"3563_CR228","first-page":"442","volume":"7","author":"K Vijayalakshmy","year":"2019","unstructured":"Vijayalakshmy K, Virmani M, Manimegalai J, Lambe U, Verma R. Transferrin polymorphism and its clinical applications. J Entomol Zoo Stud. 2019;7:442\u20134.","journal-title":"J Entomol Zoo Stud"},{"key":"3563_CR229","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2011.11.009","volume":"158","author":"JFS Mann","year":"2012","unstructured":"Mann JFS, Stieh D, Klein K, de Stegmann DSM, Cranage MP, Shattock RJ, et al. Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen. J Control Release. 2012;158:240\u20139.","journal-title":"J Control Release"},{"key":"3563_CR230","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jocn.2015.02.002","volume":"22","author":"B Voth","year":"2015","unstructured":"Voth B, Nagasawa DT, Pelargos PE, Chung LK, Ung N, Gopen Q, et al. Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment. J Clin Neurosci. 2015;22:1071\u20136.","journal-title":"J Clin Neurosci"},{"key":"3563_CR231","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s11095-008-9616-1","volume":"25","author":"CD Hein","year":"2008","unstructured":"Hein CD, Liu X-M, Wang D. Click chemistry, a powerful tool for pharmaceutical sciences. Pharm Res. 2008;25:2216\u201330.","journal-title":"Pharm Res"},{"key":"3563_CR232","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1021\/cr0783479","volume":"108","author":"M Meldal","year":"2008","unstructured":"Meldal M, Torn\u00f8e CW. Cu-catalyzed azide\u2212 alkyne cycloaddition. Chem Rev. 2008;108:2952\u20133015.","journal-title":"Chem Rev"},{"key":"3563_CR233","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.biomac.5b01660","volume":"17","author":"KS Anseth","year":"2016","unstructured":"Anseth KS, Klok H-A. Click chemistry in biomaterials, nanomedicine, and drug delivery. Biomacromol. 2016;17:1\u20133.","journal-title":"Biomacromol"},{"key":"3563_CR234","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","volume":"34","author":"Z Liu","year":"2013","unstructured":"Liu Z, Jiang M, Kang T, Miao D, Gu G, Song Q, et al. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration. Biomaterials. 2013;34:3870\u201381.","journal-title":"Biomaterials"},{"key":"3563_CR235","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6:268\u201386.","journal-title":"Acta Pharm Sin B"},{"key":"3563_CR236","doi-asserted-by":"publisher","first-page":"16890","DOI":"10.1039\/C5NR02831K","volume":"7","author":"A Tomitaka","year":"2015","unstructured":"Tomitaka A, Arami H, Gandhi S, Krishnan KM. Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale. 2015;7:16890\u20138.","journal-title":"Nanoscale"},{"key":"3563_CR237","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijbiomac.2017.08.155","volume":"107","author":"H Li","year":"2018","unstructured":"Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, et al. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol. 2018;107:204\u201311.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR238","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","volume":"38","author":"G Guidotti","year":"2017","unstructured":"Guidotti G, Brambilla L, Rossi D. Cell-penetrating peptides: from basic research to clinics. Trends Pharmacol Sci. 2017;38:406\u201324.","journal-title":"Trends Pharmacol Sci"},{"key":"3563_CR239","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/biom9010022","volume":"9","author":"S Silva","year":"2019","unstructured":"Silva S, Almeida AJ, Vale N. Combination of cell-penetrating peptides with nanoparticles for therapeutic application: a review. Biomolecules. 2019;9:22.","journal-title":"Biomolecules"},{"key":"3563_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119501","volume":"225","author":"Y He","year":"2019","unstructured":"He Y, Guo S, Wu L, Chen P, Wang L, Liu Y, et al. Near-infrared boosted ROS responsive siRNA delivery and cancer therapy with sequentially peeled upconversion nano-onions. Biomaterials. 2019;225:119501.","journal-title":"Biomaterials"},{"key":"3563_CR241","doi-asserted-by":"publisher","first-page":"1903296","DOI":"10.1002\/smll.201903296","volume":"15","author":"V Juang","year":"2019","unstructured":"Juang V, Chang C, Wang C, Wang H, Lo Y. pH-responsive PEG-shedding and Targeting peptide-modified nanoparticles for dual-delivery of Irinotecan and microRNA to enhance tumor-specific therapy. Small. 2019;15:1903296.","journal-title":"Small"},{"key":"3563_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119443","volume":"223","author":"G Gao","year":"2019","unstructured":"Gao G, Jiang Y-W, Jia H-R, Sun W, Guo Y, Yu X-W, et al. From perinuclear to intranuclear localization: a cell-penetrating peptide modification strategy to modulate cancer cell migration under mild laser irradiation and improve photothermal therapeutic performance. Biomaterials. 2019;223:119443.","journal-title":"Biomaterials"},{"key":"3563_CR243","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1021\/acs.bioconjchem.8b00252","volume":"29","author":"K Renault","year":"2018","unstructured":"Renault K, Fredy JW, Renard P-Y, Sabot C. Covalent modification of biomolecules through maleimide-based labeling strategies. Bioconjug Chem. 2018;29:2497\u2013513.","journal-title":"Bioconjug Chem"},{"key":"3563_CR244","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1039\/C9SC03368H","volume":"10","author":"E Kim","year":"2019","unstructured":"Kim E, Koo H. Biomedical applications of copper-free click chemistry: in vitro, in vivo, and ex vivo. Chem Sci. 2019;10:7835\u201351.","journal-title":"Chem Sci"},{"key":"3563_CR245","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/pharmaceutics14030588","volume":"14","author":"PC Pires","year":"2022","unstructured":"Pires PC, Rodrigues M, Alves G, Santos AO. Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs. Pharmaceutics. 2022;14:588.","journal-title":"Pharmaceutics"},{"key":"3563_CR246","first-page":"197","volume":"67","author":"A Bernkop-Schn\u00fcrch","year":"1999","unstructured":"Bernkop-Schn\u00fcrch A, Brandt UM, Clausen AE. Synthesis and in vitro evaluation of chitosan-cysteine conjugates. Sci Pharm. 1999;67:197\u2013208.","journal-title":"Sci Pharm"},{"key":"3563_CR247","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4314\/tjpr.v7i3.14694","volume":"7","author":"SA Sreenivas","year":"2008","unstructured":"Sreenivas SA, Pai KV. Thiolated chitosans: novel polymers for mucoadhesive drug delivery\u2013a review. Trop J Pharm Res. 2008;7:1077\u201388.","journal-title":"Trop J Pharm Res"},{"key":"3563_CR248","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jps.22780","volume":"101","author":"D Patel","year":"2012","unstructured":"Patel D, Naik S, Misra A. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain. J Pharm Sci. 2012;101:690\u2013706.","journal-title":"J Pharm Sci"},{"key":"3563_CR249","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jbm.a.31069","volume":"82","author":"LMY Yu","year":"2007","unstructured":"Yu LMY, Kazazian K, Shoichet MS. Peptide surface modification of methacrylamide chitosan for neural tissue engineering applications. J Biomed Mater Res Part A. 2007;82:243\u201355.","journal-title":"J Biomed Mater Res Part A"},{"key":"3563_CR250","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1021\/sc500634p","volume":"2","author":"VK Thakur","year":"2014","unstructured":"Thakur VK, Thakur MK. Recent advances in graft copolymerization and applications of chitosan: a review. ACS Sustain Chem Eng. 2014;2:2637\u201352.","journal-title":"ACS Sustain Chem Eng"},{"key":"3563_CR251","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ijbiomac.2016.05.054","volume":"91","author":"A Kumar","year":"2016","unstructured":"Kumar A, Vimal A, Kumar A. Why Chitosan? From properties to perspective of mucosal drug delivery. Int J Biol Macromol. 2016;91:615\u201322.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR252","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/md13031133","volume":"13","author":"I Younes","year":"2015","unstructured":"Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, properties and applications. Mar Drugs. 2015;13:1133\u201374.","journal-title":"Mar Drugs"},{"key":"3563_CR253","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.carbpol.2012.05.028","volume":"90","author":"S D\u00fcnnhaupt","year":"2012","unstructured":"D\u00fcnnhaupt S, Barthelmes J, Thurner CC, Waldner C, Sakloetsakun D, Bernkop-Schn\u00fcrch A. S-protected thiolated chitosan: Synthesis and in vitro characterization. Carbohyd Polym. 2012;90:765\u201372.","journal-title":"Carbohyd Polym"},{"key":"3563_CR254","unstructured":"Corrales HFZ. Chitosan, chitosan derivatives and their biomedical applications. Biol Act Appl Mar Polysaccharides. 2017;87."},{"key":"3563_CR255","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jconrel.2014.04.043","volume":"186","author":"L Upadhyaya","year":"2014","unstructured":"Upadhyaya L, Singh J, Agarwal V, Tewari RP. The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications. J Control Release. 2014;186:54\u201387.","journal-title":"J Control Release"},{"key":"3563_CR256","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/adhm.201600095","volume":"5","author":"Q Gu","year":"2016","unstructured":"Gu Q, Tomaskovic-Crook E, Lozano R, Chen Y, Kapsa RM, Zhou Q, et al. Functional 3D neural mini-tissues from printed gel-based bioink and human neural stem cells. Adv Healthcare Mater. 2016;5:1429\u201338.","journal-title":"Adv Healthcare Mater"},{"key":"3563_CR257","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1007\/s12035-015-9333-9","volume":"53","author":"Y Ding","year":"2016","unstructured":"Ding Y, Qiao Y, Wang M, Zhang H, Li L, Zhang Y, et al. Enhanced neuroprotection of acetyl-11-keto-\u03b2-boswellic acid (AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathways. Mol Neurobiol. 2016;53:3842\u201353.","journal-title":"Mol Neurobiol"},{"key":"3563_CR258","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.msec.2016.04.041","volume":"65","author":"SMR Wahba","year":"2016","unstructured":"Wahba SMR, Darwish AS, Kamal SM. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer\u2019s disease in ovariectomized albino-rat model. Mater Sci Eng C. 2016;65:151\u201363.","journal-title":"Mater Sci Eng C"},{"key":"3563_CR259","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/polym10030267","volume":"10","author":"MTM Ways","year":"2018","unstructured":"Ways MTM, Lau WM, Khutoryanskiy VV. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers. 2018;10:267.","journal-title":"Polymers"},{"key":"3563_CR260","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.carbpol.2018.09.065","volume":"203","author":"MH Turabee","year":"2019","unstructured":"Turabee MH, Jeong TH, Ramalingam P, Kang JH, Ko YT. N, N, N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor. Carbohydr Polym. 2019;203:302\u20139.","journal-title":"Carbohydr Polym"},{"key":"3563_CR261","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejps.2018.03.030","volume":"118","author":"AS Sedeky","year":"2018","unstructured":"Sedeky AS, Khalil IA, Hefnawy A, El-Sherbiny IM. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line. Eur J Pharm Sci. 2018;118:103\u201312.","journal-title":"Eur J Pharm Sci"},{"key":"3563_CR262","doi-asserted-by":"crossref","unstructured":"Yadav KS, Nijhawan HP, Nirale P, Singhal D, Soni G. Efficient nose-to-brain delivery of chitosan-coated resveratrol nanoemulsion in rats: Formulation optimized using D-optimal mixture design. J Dispers Sci Technol 2025;1\u201315.","DOI":"10.1080\/01932691.2025.2483899"},{"key":"3563_CR263","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.880377","volume":"13","author":"J Frigaard","year":"2022","unstructured":"Frigaard J, Jensen JL, Galtung HK, Hiorth M. The potential of chitosan in nanomedicine: an overview of the cytotoxicity of chitosan based nanoparticles. Front Pharmacol. 2022;13:880377.","journal-title":"Front Pharmacol"},{"key":"3563_CR264","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1002\/jps.22528","volume":"100","author":"SRK Vaka","year":"2011","unstructured":"Vaka SRK, Murthy SN, Repka MA, Nagy T. Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci. 2011;100:3139\u201345.","journal-title":"J Pharm Sci"},{"key":"3563_CR265","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jps.20718","volume":"96","author":"L Illum","year":"2007","unstructured":"Illum L. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci. 2007;96:473\u201383.","journal-title":"J Pharm Sci"},{"key":"3563_CR266","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.yrtph.2009.09.015","volume":"56","author":"P Baldrick","year":"2010","unstructured":"Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol. 2010;56:290\u20139.","journal-title":"Regul Toxicol Pharmacol"},{"key":"3563_CR267","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/polym15132867","volume":"15","author":"R Rom\u00e1n-Doval","year":"2023","unstructured":"Rom\u00e1n-Doval R, Torres-Arellanes SP, Tenorio-Barajas AY, G\u00f3mez-S\u00e1nchez A, Valencia-Lazcano AA. Chitosan: Properties and its application in agriculture in context of molecular weight. Polymers. 2023;15:2867.","journal-title":"Polymers"},{"key":"3563_CR268","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.carbpol.2013.08.027","volume":"99","author":"H Bshara","year":"2014","unstructured":"Bshara H, Osman R, Mansour S, El-Shamy AE-HA. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohydr Polym. 2014;99:297\u2013305.","journal-title":"Carbohydr Polym"},{"key":"3563_CR269","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijpharm.2012.10.049","volume":"441","author":"S Jose","year":"2013","unstructured":"Jose S, Ansa CR, Cinu TA, Chacko AJ, Aleykutty NA, Ferreira SV, et al. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting. Int J Pharm. 2013;441:516\u201326.","journal-title":"Int J Pharm"},{"key":"3563_CR270","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","volume":"400","author":"D Vllasaliu","year":"2010","unstructured":"Vllasaliu D, Exposito-Harris R, Heras A, Casettari L, Garnett M, Illum L, et al. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. Int J Pharm. 2010;400:183\u201393.","journal-title":"Int J Pharm"},{"key":"3563_CR271","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1517\/17425247.2014.894504","volume":"11","author":"S Md","year":"2014","unstructured":"Md S, Haque S, Fazil M, Kumar M, Baboota S, Sahni JK, et al. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC\/mass spectrometry method. Expert Opin Drug Deliv. 2014;11:827\u201342.","journal-title":"Expert Opin Drug Deliv"},{"key":"3563_CR272","unstructured":"Administration USF and D. CDRH: Center for Devices and Radiological Health. Urogynecologic surgical mesh: Update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. 2011;1\u201315."},{"key":"3563_CR273","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.athoracsur.2008.09.046","volume":"87","author":"RWJ Millner","year":"2009","unstructured":"Millner RWJ, Lockhart AS, Bird H, Alexiou C. A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery. Ann Thorac Surg. 2009;87:e13\u20134. https:\/\/doi.org\/10.1016\/j.athoracsur.2008.09.046.","journal-title":"Ann Thorac Surg"},{"key":"3563_CR274","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-981-96-2629-8_5","volume-title":"Chitosan: green derivatization and applications","author":"KM Zia","year":"2025","unstructured":"Zia KM. Regulatory status and clinical trials of chitosan and derivatives. In: Chitosan: green derivatization and applications. Springer; 2025. p. 115\u201334."},{"key":"3563_CR275","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/B978-0-443-13997-0.00014-X","volume-title":"Chitosan-based nanoparticles for biomedical applications","author":"SO Enejiyon","year":"2025","unstructured":"Enejiyon SO, Komolafe LI, Ahmad NH, Muhammad FE, Okoye UM, Oyewole OA, et al. Chitosan-based nanoparticles for the treatment of neurological disorders. In: Chitosan-based nanoparticles for biomedical applications. Elsevier; 2025. p. 289\u2013309."},{"key":"3563_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.","journal-title":"Signal Transduct Target Ther"},{"key":"3563_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxmate.2026.102940","volume":"13","author":"GI Edo","year":"2026","unstructured":"Edo GI, Ali ABM, Ndudi W, Oghroro EEA, Jikah AN, Yousif E, et al. From molecular design to clinical translation: a critical and integrated review of chitosan structure\u2013property performance relationships. Next Mater. 2026;13:102940.","journal-title":"Next Mater"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03563-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:03:14Z","timestamp":1790838194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03563-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":277,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03563-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest related to the publication of this manuscript. No financial, personal, or professional relationships with individuals or organizations have influenced the research, authorship, or publication of this work. All authors have reviewed the manuscript and approved its submission in its current form.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"317"}}